Vaarad Ventures: Nitin Datanwala exits board after term

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Nitin Hariyantalal Datanwala ceased as Independent Director on August 10, 2026
  • Departure followed completion of second and final term
  • Disclosure filed under Regulation 30 of SEBI Listing Regulations
  • Company cited administrative oversight for delayed filing
powered bylight_fuzz_icon
50092397

*this image is generated using AI for illustrative purposes only.

Vaarad Ventures Limited announced that Mr. Nitin Hariyantalal Datanwala ceased to be an Independent Director on August 10, 2026. The departure follows the completion of his second and final term in office.

The company filed the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Datanwala, holding DIN 00047544, stepped down at the close of business hours on the specified date.

Governance Update

The cessation was routine, resulting from tenure limits rather than resignation or removal. Vaarad Ventures confirmed there are no material reasons beyond the completion of the term.

Compliance Note

The company acknowledged a delay in submitting this intimation to the BSE. Management attributed the lapse to an internal administrative oversight and stated that steps have been taken to strengthen compliance mechanisms.

Historical Stock Returns for Vaarad Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-3.88%-6.90%-8.24%0.0%

Who has been appointed or nominated as the new Independent Director to fill the vacancy left by Mr. Datanwala?

What specific measures has Vaarad Ventures implemented to prevent future delays in regulatory filings to the BSE?

How might the change in board composition impact the company's strategic direction or governance oversight in the coming fiscal year?

Vaarad Ventures reports net loss for FY26

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Vaarad Ventures Limited reported a consolidated net loss of ₹21.90 lakh for the year ended March 31, 2026, with zero revenue from operations. The standalone net loss for the period was ₹15.47 lakh. The Board of Directors approved the audited financial results on May 28, 2026.

powered bylight_fuzz_icon
41602132

*this image is generated using AI for illustrative purposes only.

Vaarad Ventures Limited reported a consolidated net loss of ₹21.90 lakh for the year ended March 31, 2026, with zero revenue from operations. The company's standalone net loss for the same period stood at ₹15.47 lakh. The Board of Directors approved the audited financial results on May 28, 2026.

For the quarter ended March 31, 2026, the company recorded a consolidated net loss of ₹3.95 lakh and a standalone net loss of ₹1.99 lakh. Revenue from operations remained at 0.00 for both the quarter and the full year across standalone and consolidated financial statements.

The paid-up equity share capital remained constant at ₹2,499.03 lakh, with a face value of Re. 1 each. Earnings per share (EPS) for the year ended March 31, 2026, was reported as (0.010) on a basic and diluted basis.

The Audit Committee reviewed the results, and the Statutory Auditors audited the financial statements. The detailed results are available on the BSE website and the company's official website.

Financial Results for the Year Ended March 31, 2026

Particulars Standalone Year Ended 31/03/2026 Consolidated Year Ended 31/03/2026
Revenue from Operations 0.00 0.00
Net Profit / (Loss) for the period (15.47) (21.90)
Paid up Equity Share Capital 2499.03 2499.03
Earnings per share (Basic & Diluted) (0.010) (0.010)

Figures in ₹ Lakhs

Historical Stock Returns for Vaarad Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-3.88%-6.90%-8.24%0.0%

What strategic initiatives does Vaarad Ventures plan to implement to generate revenue from operations in the upcoming fiscal year?

How does the company intend to manage its operating expenses to reduce the widening gap between standalone and consolidated net losses?

With zero revenue and constant paid-up capital, are there plans to raise fresh capital or secure funding to sustain operations?

More News on Vaarad Ventures

Must Read Next

Stocks

USFDA issues two observations at Dr. Reddy's Mexico facility 28 mins ago
Strides Pharma Science receives three USFDA remarks at Alathur facility 28 mins ago
1 Year Returns:-8.24%